Lung Cancer Clinical Trial

Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study

Summary

This is a Phase 3 study aimed at investigating the effects of a personalized exercise program (PEP) in NSCLC patients (stage I, II, IIIa) and secondary lung cancer patients undergoing surgical treatment at the University of Utah and comparing the intervention to the current standard of care (no exercise program).

View Full Description

Full Description

This is a Phase 3 study aimed at investigating the effects of a personalized exercise program (PEP) in NSCLC patients (stage I, II, IIIa) and secondary lung cancer patients undergoing surgical treatment at the University of Utah and comparing the intervention to the current standard of care (no exercise program).

Eligible patients will be randomized between two arms (1:1 ratio) prior to the surgery and will be followed for approximately 6 months post-surgery:

An Intervention Arm (referred to in materials as Group 1) which features pre- and post-surgery PEP interventions.
A Control Arm (referred to in materials as Group 2) which does not include a personalized exercise program (the standard of care). Patients randomized to the Control Arm will be given the opportunity to participate in a PEP-intervention session providing exercise counseling after the 6 month assessment and will receive a free activity tracker for their participation.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male or female subject aged ≥ 18 years.
Diagnosis of primary lung cancer stage I, II, or IIIa OR secondary lung cancer.
Disease amenable to surgical resection in the opinion of the treating surgeon.
Patients must be able to follow directions and complete questionnaires and exercise diaries in English.
Patients must agree to be randomly assigned to either Intervention or Control Group.

Exclusion Criteria:

Deemed ineligible for surgery by the enrolling physician
Abnormalities on screening physical exam judged by study physicians or supervising physical therapist to contraindicate participation in exercise program compliance.
Alcohol or drug abuse as judged by study physicians.
Significant mental or emotional problems that would interfere with study participation will be assessed by the NCCN Distress Thermometer. Any value higher than 7 will trigger further intervention, but ultimately enrollment into the clinical trial will be determined by the enrolling physician.

Study is for people with:

Lung Cancer

Phase:

Phase 3

Estimated Enrollment:

200

Study ID:

NCT03306992

Recruitment Status:

Completed

Sponsor:

University of Utah

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Huntsman Cancer Institute
Salt Lake City Utah, 84112, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 3

Estimated Enrollment:

200

Study ID:

NCT03306992

Recruitment Status:

Completed

Sponsor:


University of Utah

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.